Rebound Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $102M

  • Investors
  • 1

Rebound Therapeutics General Information

Description

Developer of medical devices designed to offer medical devices for minimally invasive surgery (MIS) procedures. The company's medical devices include MIS access and therapeutic devices that offer state-of-the-art imaging and illumination technologies and are used for a variety of surgical procedures including neurosurgery, spine and orthopedic surgery, thoracic and general abdominal surgery, enabling physicians to carry out MIS procedures for the displacement of the large, complex and capital equipment in operating rooms

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 13844 Alton Parkway
  • Suite 120
  • Irvine, CA 92618
  • United States
Primary Industry
Surgical Devices
Corporate Office
  • 13844 Alton Parkway
  • Suite 120
  • Irvine, CA 92618
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rebound Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Sep-2019 $102M Completed Generating Revenue
2. Early Stage VC (Series B) 25-Jul-2017 Completed Stealth
1. Seed Round 29-Dec-2015 $3.76M $3.76M Completed Stealth
To view Rebound Therapeutics’s complete valuation and funding history, request access »

Rebound Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Rebound Therapeutics’s complete cap table history, request access »

Rebound Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices designed to offer medical devices for minimally invasive surgery (MIS) procedures. The comp
Surgical Devices
Irvine, CA

San Diego, CA
 

Portage, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rebound Therapeutics Competitors (2)

One of Rebound Therapeutics’s 2 competitors is NuVasive, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NuVasive Formerly VC-backed San Diego, CA
Stryker Formerly VC-backed Portage, MI
You’re viewing 2 of 2 competitors. Get the full list »

Rebound Therapeutics Patents

Rebound Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020336255-A1 Cannula and obturator system Inactive 23-Aug-2019
CA-3149499-A1 Cannula and obturator system Pending 23-Aug-2019
EP-4017385-A1 Cannula and obturator system Inactive 23-Aug-2019
EP-4017385-A4 Cannula and obturator system Inactive 23-Aug-2019
JP-2022544745-A Cannula and obturator system Pending 23-Aug-2019 A61B1/042
To view Rebound Therapeutics’s complete patent history, request access »

Rebound Therapeutics Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invus Opportunities Venture Capital Minority
Wexford Capital Asset Manager Minority
To view Rebound Therapeutics’s complete investors history, request access »

Rebound Therapeutics FAQs

  • When was Rebound Therapeutics founded?

    Rebound Therapeutics was founded in 2015.

  • Where is Rebound Therapeutics headquartered?

    Rebound Therapeutics is headquartered in Irvine, CA.

  • What industry is Rebound Therapeutics in?

    Rebound Therapeutics’s primary industry is Surgical Devices.

  • Is Rebound Therapeutics a private or public company?

    Rebound Therapeutics is a Private company.

  • What is the current valuation of Rebound Therapeutics?

    The current valuation of Rebound Therapeutics is .

  • What is Rebound Therapeutics’s current revenue?

    The current revenue for Rebound Therapeutics is .

  • How much funding has Rebound Therapeutics raised over time?

    Rebound Therapeutics has raised $20.3M.

  • Who are Rebound Therapeutics’s investors?

    Invus Opportunities and Wexford Capital have invested in Rebound Therapeutics.

  • Who are Rebound Therapeutics’s competitors?

    NuVasive and Stryker are competitors of Rebound Therapeutics.

  • When was Rebound Therapeutics acquired?

    Rebound Therapeutics was acquired on 09-Sep-2019.

  • Who acquired Rebound Therapeutics?

    Rebound Therapeutics was acquired by Integra Lifesciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »